Detalhe da pesquisa
1.
VCP/p97 inhibitor CB-5083 modulates muscle pathology in a mouse model of VCP inclusion body myopathy.
J Transl Med
; 20(1): 21, 2022 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34998409
2.
A p97/Valosin-Containing Protein Inhibitor Drug CB-5083 Has a Potent but Reversible Off-Target Effect on Phosphodiesterase-6.
J Pharmacol Exp Ther
; 378(1): 31-41, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33931547
3.
Skeletal muscle effects of antisense oligonucleotides targeting glycogen synthase 1 in a mouse model of Pompe disease.
bioRxiv
; 2024 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38464319
4.
Prevalence of Frontotemporal Dementia in Females of 5 Hispanic Families With R159H VCP Multisystem Proteinopathy.
Neurol Genet
; 9(1): e200037, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36644447
5.
A clinicopathologic study of malignancy in VCP-associated multisystem proteinopathy.
Orphanet J Rare Dis
; 17(1): 272, 2022 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35841038
6.
Early embryonic lethality in complex I associated p.L104P Nubpl mutant mice.
Orphanet J Rare Dis
; 17(1): 386, 2022 10 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36280881